You can take part in medical research improvements
Positive results for a Clinical Study conducted with Regeneron Pharmaceuticals
ALYATEC is pleased and proud to announce the publication of positive results obtained in a clinical study conducted for the American company Regeneron Pharmaceuticals.
This phase 2 study completed in May 2020 aimed to evaluate the efficacy of a drug candidate for asthmatic patients allergic to cat.
These major results were presented for the first time at the 2021 AAAAI congress.